Basilea Pharmaceutica AG (BPMUF)
Basilea Pharmaceutica Market Cap : 871.16M for Feb. 6, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| EvoNext Holdings SA | 7.933M |
| Kuros Biosciences Ltd. | 1.250B |
| Santhera Pharmaceuticals Holding AG | 211.18M |
| BeOne Medicines Ltd. | 39.16B |
| AC Immune SA | 315.88M |
Market Cap Related Metrics
| PS Ratio | 3.614 |
| PEG Ratio | 0.355 |
| Price to Free Cash Flow | 10.94 |
| Price | 71.00 |
| Earnings Yield | 8.67% |
| PEGY Ratio | 0.355 |
| Operating PE Ratio | 11.25 |
| Normalized PE Ratio | 11.54 |